Drug Profile
Research programme: gastroenterology therapies - TAP Pharmaceutical
Alternative Names: Acid-related disease therapies - TAP Pharmaceutical Products; Gastroenterology therapies research programme - TAP Pharmaceutical ProductsLatest Information Update: 13 Feb 2008
Price :
$50
*
At a glance
- Originator TAP Pharmaceutical Products
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 13 Feb 2008 No development reported - Preclinical for Gastrointestinal disorders in USA (unspecified route)
- 30 Aug 2005 Preclinical trials in Gastrointestinal disorders in USA (unspecified route)